Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma
Background: Mantle cell lymphoma (MCL) is genetically characterized by the t(11;14)(q13;q32) translocation and a high number of secondary chromosomal alterations. The contribution of DNA methylation to MCL lymphomagenesis is not well known. We sought to identify epigenetically silenced genes in thes...
| Autores: | , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2011 |
| País: | España |
| Institución: | Universidad de Barcelona |
| Repositorio: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/43815 |
| Acceso en línea: | https://hdl.handle.net/2445/43815 |
| Access Level: | acceso abierto |
| Palabra clave: | Cicle cel·lular Limfomes Genètica molecular Carcinogènesi Cell cycle Lymphomas Molecular genetics Carcinogenesis |
| id |
ES_9fbfcc708da2bbba38504243e4c5b29c |
|---|---|
| oai_identifier_str |
oai:diposit.ub.edu:2445/43815 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell LymphomaEnjuanes, AnnaFernàndez Pascual, VerònicaHernández, LuisNavarro, AlbaBeà Bobet, Sílvia M.Pinyol, MagdaLópez Guillermo, ArmandoRosenwald, AndreasOtt, GermanCampo Güerri, EliasJares Gerboles, PedroCicle cel·lularLimfomesGenètica molecularCarcinogènesiCell cycleLymphomasMolecular geneticsCarcinogenesisBackground: Mantle cell lymphoma (MCL) is genetically characterized by the t(11;14)(q13;q32) translocation and a high number of secondary chromosomal alterations. The contribution of DNA methylation to MCL lymphomagenesis is not well known. We sought to identify epigenetically silenced genes in these tumours that might have clinical relevance. Methodology/Principal Findings: To identify potential methylated genes in MCL we initially investigated seven MCL cell lines treated with epigenetic drugs and gene expression microarray profiling. The methylation status of selected candidate genes was validated by a quantitative assay and subsequently analyzed in a series of primary MCL (n=38). After pharmacological reversion we identified 252 potentially methylated genes. The methylation analysis of a subset of these genes (n=25) in the MCL cell lines and normal B lymphocytes confirmed that 80% of them were methylated in the cell lines but not in normal lymphocytes. The subsequent analysis in primary MCL identified five genes (SOX9,HOXA9,AHR,NR2F2 ,and ROBO1) frequently methylated in these tumours. The gene methylation events tended to occur in the same primary neoplasms and correlated with higher proliferation, increased number of chromosomal abnormalities, and shorter survival of the patients. Conclusions: We have identified a set of genes whose methylation degree and gene expression levels correlate with aggressive clinicopathological features of MCL. Our findings also suggest that a subset of MCL might show a CpG island methylator phenotype (CIMP) that may influence the behaviour of the tumours.Public Library of Science (PLoS)2011info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/43815Articles publicats en revistes (Fonaments Clínics)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0019736PLoS One, 2011, vol. 6, num. 5, p. e19736http://dx.doi.org/10.1371/journal.pone.0019736cc-by (c) Enjuanes, A. et al., 2011http://creativecommons.org/licenses/by/3.0/esinfo:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/438152026-05-27T06:46:51Z |
| dc.title.none.fl_str_mv |
Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma |
| title |
Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma |
| spellingShingle |
Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma Enjuanes, Anna Cicle cel·lular Limfomes Genètica molecular Carcinogènesi Cell cycle Lymphomas Molecular genetics Carcinogenesis |
| title_short |
Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma |
| title_full |
Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma |
| title_fullStr |
Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma |
| title_full_unstemmed |
Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma |
| title_sort |
Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma |
| dc.creator.none.fl_str_mv |
Enjuanes, Anna Fernàndez Pascual, Verònica Hernández, Luis Navarro, Alba Beà Bobet, Sílvia M. Pinyol, Magda López Guillermo, Armando Rosenwald, Andreas Ott, German Campo Güerri, Elias Jares Gerboles, Pedro |
| author |
Enjuanes, Anna |
| author_facet |
Enjuanes, Anna Fernàndez Pascual, Verònica Hernández, Luis Navarro, Alba Beà Bobet, Sílvia M. Pinyol, Magda López Guillermo, Armando Rosenwald, Andreas Ott, German Campo Güerri, Elias Jares Gerboles, Pedro |
| author_role |
author |
| author2 |
Fernàndez Pascual, Verònica Hernández, Luis Navarro, Alba Beà Bobet, Sílvia M. Pinyol, Magda López Guillermo, Armando Rosenwald, Andreas Ott, German Campo Güerri, Elias Jares Gerboles, Pedro |
| author2_role |
author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Cicle cel·lular Limfomes Genètica molecular Carcinogènesi Cell cycle Lymphomas Molecular genetics Carcinogenesis |
| topic |
Cicle cel·lular Limfomes Genètica molecular Carcinogènesi Cell cycle Lymphomas Molecular genetics Carcinogenesis |
| description |
Background: Mantle cell lymphoma (MCL) is genetically characterized by the t(11;14)(q13;q32) translocation and a high number of secondary chromosomal alterations. The contribution of DNA methylation to MCL lymphomagenesis is not well known. We sought to identify epigenetically silenced genes in these tumours that might have clinical relevance. Methodology/Principal Findings: To identify potential methylated genes in MCL we initially investigated seven MCL cell lines treated with epigenetic drugs and gene expression microarray profiling. The methylation status of selected candidate genes was validated by a quantitative assay and subsequently analyzed in a series of primary MCL (n=38). After pharmacological reversion we identified 252 potentially methylated genes. The methylation analysis of a subset of these genes (n=25) in the MCL cell lines and normal B lymphocytes confirmed that 80% of them were methylated in the cell lines but not in normal lymphocytes. The subsequent analysis in primary MCL identified five genes (SOX9,HOXA9,AHR,NR2F2 ,and ROBO1) frequently methylated in these tumours. The gene methylation events tended to occur in the same primary neoplasms and correlated with higher proliferation, increased number of chromosomal abnormalities, and shorter survival of the patients. Conclusions: We have identified a set of genes whose methylation degree and gene expression levels correlate with aggressive clinicopathological features of MCL. Our findings also suggest that a subset of MCL might show a CpG island methylator phenotype (CIMP) that may influence the behaviour of the tumours. |
| publishDate |
2011 |
| dc.date.none.fl_str_mv |
2011 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/43815 |
| url |
https://hdl.handle.net/2445/43815 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0019736 PLoS One, 2011, vol. 6, num. 5, p. e19736 http://dx.doi.org/10.1371/journal.pone.0019736 |
| dc.rights.none.fl_str_mv |
cc-by (c) Enjuanes, A. et al., 2011 http://creativecommons.org/licenses/by/3.0/es info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
cc-by (c) Enjuanes, A. et al., 2011 http://creativecommons.org/licenses/by/3.0/es |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Public Library of Science (PLoS) |
| publisher.none.fl_str_mv |
Public Library of Science (PLoS) |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Fonaments Clínics) reponame:Dipòsit Digital de la UB instname:Universidad de Barcelona |
| instname_str |
Universidad de Barcelona |
| reponame_str |
Dipòsit Digital de la UB |
| collection |
Dipòsit Digital de la UB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869414954240573440 |
| score |
15,300719 |